Pozen's Suit Over Treximet ANDAs Stays Intact

Law360, New York (October 15, 2010, 4:18 PM EDT) -- The judge overseeing Pozen Inc.’s bench trial against Par Pharmaceutical Cos. Inc., Mylan Inc.’s Alphapharm Pty. Ltd. and Dr. Reddy’s Laboratories Inc. over generic versions of the migraine treatment Treximet denied the defendants any telling victories Thursday, leaving the parties to wait to find out if the market for the drug will be thrown open.

Pozen faced off against the generic-drug makers on Friday for a fourth and likely final day, after Judge Leonard Davis of the U.S. District Court for the Eastern District of Texas...
To view the full article, register now.